Cigna Corporation Financial Statements (CI)
|
|
Report date
|
|
|
25.02.2021 |
24.02.2022 |
23.02.2023 |
31.12.2023 |
29.02.2024 |
|
31.10.2024 |
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
160 577 |
174 272 |
180 642 |
195 265 |
195 187 |
|
230 668 |
Operating Income, bln rub |
|
|
8 714 |
8 352 |
9 503 |
5 164 |
8 536 |
|
7 429 |
EBITDA, bln rub |
? |
|
15 108 |
10 913 |
12 550 |
5 164 |
9 987 |
|
7 775 |
Net profit, bln rub |
? |
|
8 458 |
5 370 |
6 704 |
5 164 |
5 164 |
|
2 386 |
|
OCF, bln rub |
? |
|
10 350 |
7 191 |
8 656 |
0.000 |
11 813 |
|
6 618 |
CAPEX, bln rub |
? |
|
1 094 |
1 154 |
1 295 |
0.000 |
1 573 |
|
1 434 |
FCF, bln rub |
? |
|
9 256 |
6 037 |
7 361 |
0.000 |
10 240 |
|
5 184 |
Dividend payout, bln rub
|
|
|
15.0 |
1 341 |
1 384 |
0.000 |
1 450 |
|
1 541 |
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
Dividend payout ratio, %
|
|
|
0.18% |
25.0% |
20.6% |
0.00% |
28.1% |
|
64.6% |
|
OPEX, bln rub |
|
|
257 509 |
288 953 |
13 186 |
190 101 |
186 651 |
|
137 142 |
Cost of production, bln rub |
|
|
32 710 |
33 562 |
32 206 |
0.000 |
36 287 |
|
37 762 |
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
Interest expenses, bln rub |
|
|
1 438 |
1 208 |
1 228 |
0.000 |
1 446 |
|
1 433 |
|
Assets, bln rub |
|
|
155 451 |
154 889 |
143 932 |
0.000 |
152 761 |
|
157 639 |
Net Assets, bln rub |
? |
|
50 321 |
47 112 |
44 872 |
46 223 |
46 223 |
|
42 095 |
Debt, bln rub |
|
|
32 919 |
33 670 |
31 093 |
0.000 |
31 480 |
|
32 802 |
Cash, bln rub |
|
|
11 513 |
6 001 |
6 829 |
0.000 |
7 822 |
|
5 888 |
Net debt, bln rub |
|
|
21 406 |
27 669 |
24 264 |
0.00 |
23 658 |
|
26 914 |
|
Ordinary share price, rub |
|
|
208.2 |
229.6 |
331.3 |
299.5 |
299.5 |
|
318.9 |
Number of ordinary shares, mln |
|
|
365.0 |
338.0 |
309.5 |
296.9 |
293.9 |
|
278.5 |
|
Market cap, bln rub |
|
|
75 981 |
77 606 |
102 565 |
88 901 |
88 006 |
|
88 800 |
EV, bln rub |
? |
|
97 387 |
105 275 |
126 829 |
88 901 |
111 664 |
|
115 714 |
Book value, bln rub |
|
|
-29 506 |
-32 801 |
-33 431 |
46 223 |
-28 899 |
|
-32 070 |
|
EPS, rub |
? |
|
23.2 |
15.9 |
21.7 |
17.4 |
17.6 |
|
8.57 |
FCF/share, rub |
|
|
25.4 |
17.9 |
23.8 |
0.00 |
34.8 |
|
18.6 |
BV/share, rub |
|
|
-80.8 |
-97.1 |
-108.0 |
155.7 |
-98.3 |
|
-115.2 |
|
EBITDA margin, % |
? |
|
9.41% |
6.26% |
6.95% |
2.64% |
5.12% |
|
3.37% |
Net margin, % |
? |
|
5.27% |
3.08% |
3.71% |
2.64% |
2.65% |
|
1.03% |
FCF yield, % |
? |
|
12.2% |
7.78% |
7.18% |
0.00% |
11.6% |
|
5.84% |
ROE, % |
? |
|
16.8% |
11.4% |
14.9% |
11.2% |
11.2% |
|
5.67% |
ROA, % |
? |
|
5.44% |
3.47% |
4.66% |
|
3.38% |
|
1.51% |
|
P/E |
? |
|
8.98 |
14.5 |
15.3 |
17.2 |
17.0 |
|
37.2 |
P/FCF |
|
|
8.21 |
12.9 |
13.9 |
|
8.59 |
|
17.1 |
P/S |
? |
|
0.47 |
0.45 |
0.57 |
0.46 |
0.45 |
|
0.38 |
P/BV |
? |
|
-2.58 |
-2.37 |
-3.07 |
1.92 |
-3.05 |
|
-2.77 |
EV/EBITDA |
? |
|
6.45 |
9.65 |
10.1 |
17.2 |
11.2 |
|
14.9 |
Debt/EBITDA |
|
|
1.42 |
2.54 |
1.93 |
0.00 |
2.37 |
|
3.46 |
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.00% |
|
0.00% |
|
0 |
|
CAPEX/Revenue, % |
|
|
0.68% |
0.66% |
0.72% |
0.00% |
0.81% |
|
0.62% |
|
Cigna Corporation shareholders |